Minerva Neurosciences | Attività

Assets Cambiamento Data
Acadia Pharmaceuticals USD 748.96M 116.42M 2023-12
Adma Biologics USD 329.18M 19.81M 2023-12
ALKERMES USD 2.28B 92.05M 2023-09
AstraZeneca USD 96.09B 457M 2023-09
Bristol-Myers Squibb USD 91.26B 2.23B 2023-09
Clal Biotechnology ILS 182.69M 6.18M 2022-12
Compugen USD 67.61M 9.44M 2023-09
CSL USD 36.23B 786.4M 2023-06
Dynavax Technologies USD 997.1M 24.16M 2023-12
Eli Lilly USD 57.92B 3.1B 2023-09
GlaxoSmithKline GBP 60.86B 1.4B 2023-09
Grifols EUR 22.06B 631.75M 2023-09
Halozyme Therapeutics USD 1.73B 159.39M 2023-12
Ionis Pharmaceuticals USD 2.99B 56.1M 2023-12
Merck USD 106.73B 2.26B 2023-09
Neurocrine Biosciences USD 2.85B 235.1M 2023-09
Pfizer USD 215.02B 5.15B 2023-09
Roche Holding CHF 84.37B 3.78B 2023-06
Takeda JPY 14.87T 79.15B 2023-09



Minerva Neurosciences Attività - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Apr 2024.